Transcription of HIGHLIGHTS OF PRESCRIBING INFORMATION NOXAFIL. …
{{id}} {{{paragraph}}}
1 HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese HIGHLIGHTS do not include all the INFORMATION needed to useNOXAFIL safely and effectively. See full PRESCRIBING INFORMATION (posaconazole) injection, for intravenous use NOXAFIL (posaconazole) delayed-release tablets, for oral use NOXAFIL (posaconazole) oral suspension NOXAFIL PowderMix (posaconazole) for delayed-release oralsuspensionInitial Approval: 2006 --------------------------- RECENT MAJOR CHANGES --------------------------- Indications and Usage (1) 6/2021 Dosage and Administration (2) 6/2021 Contraindications (4) 1/202 2 Warnings and Precautions (5) 1/202 2 ----------------------------INDICATIONS AND USAGE ---------------------------- Noxafil is a n azole antifungal indicated as follows: Noxafil injection and Noxafil delayed-release tablets are indicatedfor the treatment of invasive aspergillosis in adults and pediatricpatients 13 years o
Noxafil oral suspension is not substitutable with Noxafil delayed-release tablets or Noxafil PowderMix for delayed-release oral suspension due to the differences in the dosing of each formulation. Therefore, follow the specific dosage recommendations for each of the formulations. (2.1, 2.2, 2.3, 2.8)
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}